In his words, the decree marks a turning point for a country that, for decades, has built a solid base in both medicines and medical devices. Martínez Moreno emphasized that the synergy between innovation, investment, and public policy will allow for the consolidation of a competitive environment capable of attracting research and advanced manufacturing projects, positioning Mexico as a key player in the global health economy. He also noted that the continuity of this type of policy will be key to boosting productivity, strengthening health autonomy, and guaranteeing a more efficient health system, supported by technology, scientific development, and international collaboration. The French Healthcare Day 2025, organized by Business France and the Embassy of France in Mexico, thus consolidated itself as a benchmark space for the Franco-Mexican dialogue on medical innovation, public policies, and strategic alliances. To learn more about this outstanding event in science, health, and society: Full note https://lasalud.mx/2025/10/15/innovacion-y-salud-reflexiones-del-french-healthcare-day-2025/ Visit our complete photo gallery on: Instagram https://www.instagram.com/lasaludmx?igsh=MWZhdm1wNGtzaG53NA== Facebook https://www.facebook.com/share/p/1A1Zzi1R5h/ This note, as well as reports, exclusive interviews, videos, podcast and more, you will find in our next special digital edition of Temas Selectos en Salud. LaSalud.mx The Journal of the Medical Community. Visit some of our special editions at https://issuu.com/grupo-mundodehoy. D.E. Javier Dávila from the Ministry of Economy, where the opportunities and challenges derived from the decree published in June of this year were discussed. The director of INEFAM highlighted that the measure not only drives investment and national production, but also opens the door to a new stage of inter-institutional collaboration between the health and economic sectors, aimed at strengthening research, technological development, and health regulation. The investment decree marks a turning point for medicines and medical devices. By: Carlos Henze Images: Lourdes Hurtado / Daniela Escartin LaSalud.mx.- The French Healthcare Day 2025, held on September 29, brought together health sector leaders from France and Mexico. Enrique Martínez Moreno, General Director of the Institute of Pharmaceutical Innovation and Research (INEFAM), shared in an exclusive interview for LaSalud.mx his analysis on the impact of the new decree to promote pharmaceutical investment and its transformative potential for the national industry. Martínez Moreno was part of a high-level dialogue table in which Guillermo Funes, president of the National Chamber of the Pharmaceutical Industry (CANIFARMA); Karla Báez, interim Executive Director of the AMIIF; Ana Riquelme, Executive Director of the AMID; and Dr.
French Healthcare Day 2025: Mexico Strengthens Its Position in the Global Health Economy
An investment decree marks a turning point for Mexico. Experts discussed how innovation, investment, and public policy will strengthen the national industry and position the country as a key player in the global health economy.